Neuphoria Therapeutics (NEUP) EV to CFO (2025)
Neuphoria Therapeutics' EV to CFO was 2050.01 in fiscal Q1 2026 (quarter ended Sep 30, 2025), down 81.8% from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) EV to CFO (2025) Analysis & Trends
On a trailing twelve-month basis, Neuphoria Therapeutics' EV to CFO was 1999.89 through Sep 30, 2025; for FY2025 (ended Jun 30, 2025), it was 11205.71.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Neuphoria Therapeutics | 443.79 Mn | 368.60 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 2,050.01 |
| Jun 30, 2025 | 11,276.65 |
| Mar 31, 2025 | 1,075.97 |
API Access
Neuphoria Therapeutics EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();